125 related articles for article (PubMed ID: 26536349)
1. Adaptive (TINT) Changes in the Tumor Bearing Organ Are Related to Prostate Tumor Size and Aggressiveness.
Adamo HH; Strömvall K; Nilsson M; Halin Bergström S; Bergh A
PLoS One; 2015; 10(11):e0141601. PubMed ID: 26536349
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
Adamo H; Hammarsten P; Hägglöf C; Dahl Scherdin T; Egevad L; Stattin P; Halin Bergström S; Bergh A
Prostate; 2019 Apr; 79(5):435-445. PubMed ID: 30536410
[TBL] [Abstract][Full Text] [Related]
3. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ.
Adamo HH; Halin Bergström S; Bergh A
PLoS One; 2015; 10(6):e0130076. PubMed ID: 26076453
[TBL] [Abstract][Full Text] [Related]
5. Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.
Strömvall K; Thysell E; Halin Bergström S; Bergh A
PLoS One; 2017; 12(5):e0176679. PubMed ID: 28472073
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles from Metastatic Rat Prostate Tumors Prime the Normal Prostate Tissue to Facilitate Tumor Growth.
Halin Bergström S; Hägglöf C; Thysell E; Bergh A; Wikström P; Lundholm M
Sci Rep; 2016 Aug; 6():31805. PubMed ID: 27550147
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta 1 overproduction in prostate cancer: effects on growth in vivo and in vitro.
Steiner MS; Barrack ER
Mol Endocrinol; 1992 Jan; 6(1):15-25. PubMed ID: 1738367
[TBL] [Abstract][Full Text] [Related]
8. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis.
Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM
Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta 1 in prostate cancer.
Steiner MS; Zhou ZZ; Tonb DC; Barrack ER
Endocrinology; 1994 Nov; 135(5):2240-7. PubMed ID: 7956947
[TBL] [Abstract][Full Text] [Related]
10. Actin filament organization of the Dunning R3327 rat prostatic adenocarcinoma system: correlation with metastatic potential.
Zachary JM; Cleveland G; Kwock L; Lawrence T; Weissman RM; Nabell L; Fried FA; Staab EV; Risinger MA; Lin S
Cancer Res; 1986 Feb; 46(2):926-32. PubMed ID: 3940653
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.
Vieweg J; Rosenthal FM; Bannerji R; Heston WD; Fair WR; Gansbacher B; Gilboa E
Cancer Res; 1994 Apr; 54(7):1760-5. PubMed ID: 8137291
[TBL] [Abstract][Full Text] [Related]
13. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines.
Tieva A; Bergh A; Damber JE
Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703
[TBL] [Abstract][Full Text] [Related]
14. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
15. Rat prostate tumors induce DNA synthesis in remote organs.
Halin Bergström S; Lundholm M; Nordstrand A; Bergh A
Sci Rep; 2022 May; 12(1):7908. PubMed ID: 35551231
[TBL] [Abstract][Full Text] [Related]
16. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
17. An animal model for the study of prostate carcinoma.
Lubaroff DM; Canfield L; Rasmussen GT; Reynolds CW
Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781
[TBL] [Abstract][Full Text] [Related]
18. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
[TBL] [Abstract][Full Text] [Related]
19. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
Zeng Y; Opeskin K; Goad J; Williams ED
Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]